Contrasting SBC Medical Group (NASDAQ:SBC) & Medpace (NASDAQ:MEDP)

SBC Medical Group (NASDAQ:SBC) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability.

Valuation & Earnings

This table compares SBC Medical Group and Medpace”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$205.42 million	2.24	$46.61 million	$0.41	10.95
Medpace	$2.11 billion	7.64	$404.39 million	$14.30	40.00

Medpace has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 89.5% of SBC Medical Group shares are held by insiders. Comparatively, 20.3% of Medpace shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares SBC Medical Group and Medpace’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.28%	24.17%	18.60%
Medpace	18.36%	91.88%	23.65%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for SBC Medical Group and Medpace, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1	0	1	0	2.00
Medpace	4	10	2	1	2.00

SBC Medical Group presently has a consensus target price of $9.00, indicating a potential upside of 100.40%. Medpace has a consensus target price of $490.82, indicating a potential downside of 14.19%. Given SBC Medical Group’s higher probable upside, equities analysts plainly believe SBC Medical Group is more favorable than Medpace.

Volatility & Risk

SBC Medical Group has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.

Summary

Medpace beats SBC Medical Group on 11 of the 14 factors compared between the two stocks.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

About Medpace

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.